Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | IKK16 | 2.0 | uM | 1 | HGF | 37.0 | 53 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | HGF | 24.0 | 43 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | HGF | 27.0 | 65 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | HGF | 30.0 | 63 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | HGF | 18.0 | 46 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | HGF | 25.5 | 38 | ||||
RA1869 | 1 | HGF | 25.0 | 35 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | HGF | 44.0 | 52 | ||||
N2759 | 1 | HGF | 35.5 | 34 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | HGF | 32.5 | 48 | ||||
RA1931 | 1 | HGF | 31.0 | 46 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 1 | HGF | 30.0 | 49 | ||||
N2586 | 1 | HGF | 27.0 | 56 | |||||||
0 | HGF | 17.0 | 43 | ||||||||
0 | HGF | 15.5 | 56 | ||||||||
0 | HGF | 16.0 | 67 | ||||||||
0 | HGF | 24.0 | 43 | ||||||||
0 | HGF | 22.0 | 30 | ||||||||
0 | HGF | 21.0 | 39 | ||||||||
RA2159 | 2 | HGF | 93.0 | 56 | |||||||
N2645 | 2 | HGF | 67.5 | 60 | |||||||
RA2708 | 2 | HGF | 43.0 | 51 | |||||||
RA2159 | JNK-IN-8 | 3.0 | uM | 2 | HGF | 108.5 | 66 | ||||
RA2159 | PH-797804 | 0.6 | uM | 2 | HGF | 126.0 | 55 | ||||
N2645 | JNK-IN-8 | 3.0 | uM | 2 | HGF | 60.0 | 51 |